Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 4—April 2011

CME ACTIVITY

Mumps Complications and Effects of Mumps Vaccination, England and Wales, 2002–2006

Chee-Fu YungComments to Author , Nick Andrews, Antoaneta Bukasa, Kevin E. Brown, and Mary E. Ramsay
Author affiliations: Authors affiliation: Health Protection Agency Centre for Infections, London, UK

Main Article

Table 1

Estimated proportion of mumps patients hospitalized and those given a code for complications by birth cohort, England and Wales, April 1, 2002–March 31, 2006*

Birth cohort
No. hospitalizations/total infections (%)
No. hospitalization complications/total infections (%)
Orchitis*
Meningitis
Pancreatitis
None
Pre-1980 451/4,455 (10.1) 158/2,376 (6.7) 26/4,455 (0.6) 21/4,455 (0.5) 260/4,455 (5.8)
1980–1989 1,782/35,152 (5.1) 811/18,814 (4.3) 118/35,152 (0.3) 114/35,152 (0.3) 791/35,152 (2.3)
1990–2006 414/3,737 (11.1) 27/1,496 (1.8) 10/3,737 (0.3) 11/3,737 (0.3) 367/3,737 (9.8)
Overall 2,647/43,344 (6.1) 996/22,686 (4.4) 154/43,344 (0.4) 146/43,344 (0.3) 1,418/43,344 (3.3)

*In male patients >12 years of age only.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO